Stockscreener 앱 받기
84.63
2.81%
2.31
시간 외 거래:
84.70
0.07
+0.08%
전일 마감가:
$82.32
열려 있는:
$82.4
하루 거래량:
340.71K
Relative Volume:
0.99
시가총액:
$1.93B
수익:
$883.37M
순이익/손실:
$71.37M
주가수익비율:
25.25
EPS:
3.3516
순현금흐름:
$150.90M
1주 성능:
+7.81%
1개월 성능:
+14.04%
6개월 성능:
-8.63%
1년 성능:
+16.63%
1일 변동 폭
$82.26
$84.91
1주일 범위
$77.14
$84.91
52주 변동 폭
$56.71
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
명칭
Ani Pharmaceuticals Inc
전화
(218) 634-3500
주소
210 MAIN STREET WEST, BAUDETTE, MN
Compare ANIP vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
84.63 | 1.87B | 883.37M | 71.37M | 150.90M | 3.3516 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | H.C. Wainwright | Buy |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-03-12 | 개시 | JP Morgan | Overweight |
| 2024-12-11 | 개시 | Leerink Partners | Outperform |
| 2024-10-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-15 | 개시 | CapitalOne | Overweight |
| 2023-08-22 | 재확인 | H.C. Wainwright | Buy |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2022-09-07 | 개시 | H.C. Wainwright | Buy |
| 2021-11-02 | 개시 | Truist | Buy |
| 2020-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-05-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 재확인 | Canaccord Genuity | Buy |
| 2017-07-31 | 개시 | Canaccord Genuity | Buy |
| 2017-02-22 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 개시 | Raymond James | Strong Buy |
| 2016-05-24 | 다운그레이드 | Standpoint Research | Buy → Hold |
| 2015-11-13 | 개시 | Standpoint Research | Buy |
| 2015-09-28 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 재확인 | Oppenheimer | Outperform |
| 2015-08-04 | 재확인 | ROTH Capital | Neutral |
| 2015-07-31 | 재확인 | Oppenheimer | Outperform |
| 2015-07-15 | 재확인 | ROTH Capital | Neutral |
| 2015-06-23 | 재확인 | Oppenheimer | Outperform |
| 2015-05-18 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 재확인 | Oppenheimer | Outperform |
| 2015-04-10 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 재확인 | ROTH Capital | Buy |
| 2015-02-18 | 재확인 | Oppenheimer | Outperform |
모두보기
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
MSN Money - MSN
Hussman Strategic Advisors Inc. Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Artemis Investment Management LLP Invests $1.71 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
ANI Pharmaceuticals (ANIP) Announces Launch of Pimozide Tablets 1 mg and 2 mg - Insider Monkey
ANI Pharmaceuticals (ANIP) Expected to Announce Earnings on Friday - MarketBeat
Zacks.com featured highlights include Mirion Technologies, Intuit and ANI Pharmaceuticals - Yahoo Finance
9 Best Drug Stocks to Buy According to Analysts - Insider Monkey
NTLA Falls 4% Despite Strong Phase III HAE Data, Initiates Rolling BLA - TradingView
ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules - MSN
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What ANI Pharmaceuticals (ANIP)'s Niche CNS Generic Launches Mean For Its Specialty-First Strategy - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After New U.S. Generic Drug Launches - Yahoo Finance
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout - TradingView
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET - marketscreener.com
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below 200-Day Moving AverageHere's Why - MarketBeat
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Momentum Stock - Yahoo Finance
How Investors Are Reacting To ANI Pharmaceuticals (ANIP) New Generics Push And ILUVIEN Trial Data - Sahm
ANI Pharmaceuticals launches generic pimozide tablets By Investing.com - Investing.com India
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics - Yahoo Finance
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target? - TradingView
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook - Yahoo Finance
Here's Why ANI Pharmaceuticals (ANIP) is a Strong Growth Stock - Yahoo Finance
ANI Pharmaceuticals launches generic pimozide tablets - Investing.com
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity - The Manila Times
ANI Pharma (ANIP) Stock: Invest or Wait? (+3.65%) 2026-04-18Stop Loss Levels - Cổng thông tin điện tử tỉnh Lào Cai
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
ANI Pharmaceuticals News Highlights Undervalued Shares And New Specialty Generics - Sahm
Assessing ANI Pharmaceuticals (ANIP) Valuation After Recent Mixed Share Price Performance - Sahm
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules - Intellectia AI
ANI Pharmaceuticals launches generic carbamazepine capsules By Investing.com - Investing.com India
ANIP News | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
Ani Pharmaceuticals’ Cook sells $38k in stock - Investing.com
Ani Pharmaceuticals Inc (ANIP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):